Lafutidine-based triple therapy for Helicobacter pylori eradication.

  title={Lafutidine-based triple therapy for Helicobacter pylori eradication.},
  author={Qian Ren and Bin Ma and Kehu Yang and Xiang Yan},
  volume={57 102-103},
BACKGROUND/AIMS For treating Helicobacter pylori infection, it is still debatable whether proton pump inhibitor can be replaced by H2-receptor antagonist without compromising efficacy. Lafutidine is a newly synthesized H2-receptor antagonist and has been shown to exhibit antisecretory action. This meta-analysis investigated the efficacy of lafutidine-based triple therapy for Helicobacter pylori infection. METHODOGY: We searched PUBMED; EMBASE, the Cochrane Library and Chinese Biomedical… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…